Drug Search Results
More Filters [+]

Fluoxymesterone

Alternative Names: fluoxymesterone, android-f, halotestin, ora-testryl, androxy
Latest Update: 2008-10-20
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: AR Agonist,ER Antagonist,Prolactin Receptor Antagonist

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: N/A

FDA Designation: None *

Approval Status: Approved

Approved Countries: Canada | Chile | Ireland | Italy | New Zealand | Pakistan | Taiwan | United States

Approved Indications: None

Known Adverse Events: None

Company: None
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Fluoxymesterone

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Recent News Events

Date

Type

Title